Caesar, Lindsay K.
Butun, Fatma A.
Robey, Matthew T.
Ayon, Navid J.
Gupta, Raveena
Dainko, David
Bok, Jin Woo
Nickles, Grant
Stankey, Robert J. https://orcid.org/0000-0003-1259-2296
Johnson, Don
Mead, David
Cank, Kristof B.
Earp, Cody E.
Raja, Huzefa A. https://orcid.org/0000-0002-0824-9463
Oberlies, Nicholas H. https://orcid.org/0000-0002-0354-8464
Keller, Nancy P. https://orcid.org/0000-0002-4386-9473
Kelleher, Neil L. https://orcid.org/0000-0002-8815-3372
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (F32 GM132679, T32 GM135066, R01 GM112739-05A1)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R44 AI140943-03)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01 CA125066)
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (R01AT009143)
NSF | ENG/OAD | Division of Electrical, Communications and Cyber Systems (NSF ECCS-2025633)
Article History
Received: 27 June 2022
Accepted: 31 January 2023
First Online: 6 March 2023
Competing interests
: The authors declare financial conflicts of interest with MicroMGx (N.L.K.), Varigen Biosciences (D.M.) and Terra Bioforge (N.L.K., D.M., M.T.R. and N.P.K.). Further, N.L.K. is a consultant for Thermo Fisher Scientific focusing on the use of Fourier-transform Mass Spectrometry in multi-Omics research. Finally, N.H.O. and H.A.R. are on the Scientific Advisory Board of Clue Genetics, and N.H.O. is on the Scientific Advisory Board of Mycosynthetix. The remaining authors declare no competing interests.